Riociguat for the treatment of chronic thromboembolic pulmonary hypertension

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10195003" target="_blank" >RIV/00216208:11110/13:10195003 - isvavai.cz</a>

Alternative codes found

RIV/00064165:_____/13:10195003

Result on the web

<a href="http://www.nejm.org/doi/full/10.1056/NEJMoa1209657" target="_blank" >http://www.nejm.org/doi/full/10.1056/NEJMoa1209657</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1056/NEJMoa1209657" target="_blank" >10.1056/NEJMoa1209657</a>

Result language

angličtina

Original language name

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension

Original language description

Riociguat, a memberof a new class of compounds (soluble guanylate cyclase stimulators), has been shown in previous clinical studies to be beneficial in the treatment of chronic thromboembolic pulmonary hypertension.In this phase 3, multicentre, randomized, double-blind, placebo-controlled study, we randomly assigned 261 patients with inoperable chronic thromboembolic pulmonary hypertension or persistent or recurrent pulmonary hypertension after pulmonary endarterectomy to receive placebo or riociguat.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FA - Cardiovascular diseases including cardio-surgery

OECD FORD branch

—

Project

—

Continuities

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Publication year

2013

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

New England Journal of Medicine

ISSN

0028-4793

e-ISSN

—

Volume of the periodical

369

Issue of the periodical within the volume

4

Country of publishing house

US - UNITED STATES

Number of pages

11

Pages from-to

319-329

UT code for WoS article

000322223900007

EID of the result in the Scopus database

—